hUC Mesenchymal Stem Cells (19#iSCLife®-CSD) Therapy for Patients With Healing Poor After Uterus Injury

• Status: Completed
• Trial end date: 2021-09-21
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of this study is verify the efficacy and safety of Human Umbilical Cord Mesenchymal Stem Cells (UC-MSC) therapy for patients with Healing Poor after Uterus Injury, and exploring the possible mechanisms of umbilical cord mesenchymal stem cell therapy in Healing Poor After Uterus Injury disease

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Sclnow Biotechnology Co., Ltd.

Criteria

Inclusion Criteria:

• Female, with BMI 19-25 kg/m^2

• Meet the clinical standard of Healing Poor After Uterus Injury

• Non smoker

• Do not accept stem cells treatment in 6 months

• Participants or their family members sign the consent form of this study

Exclusion Criteria:

• Pregnant or breast feeding women

• Age <18 or >50

• Refuse to sign the consent form

• Patients with underlying risk of medical disease history: history of diabetes, serious cardiovascular disease, severe infection, alimentary tract hemorrhage, etc.

• Serum with HIV, syphilis antibody positive

• Severe mental disease, cognitive disorder patients

• Other severe system or organ organic disease

• Participate other clinical experiments in 3 months

• Ovarian and pituitary dysfunction diseases

• With some other conditions that doctor propose not to participate